Mar 16, 2026
A bill stalled in Congress and a promising clinical trial may together be the most important developments in type 1 diabetes treatment right now.
Mar 9, 2026
Hanne Engan shares how a routine green card interview turned into nine days in ICE detention without proper care for her type 1 diabetes.
Mar 2, 2026
I sat down with Gary Scheiner CDCES to discuss insulin variability, site failures, unexplained highs, and practical strategies to get insulin working efficiently.
Feb 23, 2026
Encapsulated neonatal pig islet cells, implanted without immunosuppression in the OPF-310 trial, cut a type 1 diabetes patient’s insulin needs in half at six months, with further maturation expected.
Feb 17, 2026
We spoke with an FDA-insider about how the organization regulates diabetes tech and how recent political events have shaken up the agency.
Feb 9, 2026
Portal Diabetes is developing a fully closed-loop implantable pump that delivers insulin into the intraperitoneal cavity—achieving 4–5× faster insulin action.
Feb 2, 2026
I spoke with CDCES Gary Scheiner about how to interpret your numbers, spot trends early, and make smarter adjustments with confidence.
Jan 26, 2026
Rheos is a settings-free AID algorithm that uses health tracker wearables and AI to automate dosing for type 1 diabetes management.
Jan 19, 2026
As more insulin pumps move to pharmacy benefits, switching systems is easier than ever—but it’s also exposing serious gaps in safety, training, and support.
